+Compare
IQV
Stock ticker:
NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
38.26B

IQV Price Prediction, IQVIA Holdings AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

GET INTRADAY SIGNALS
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for IQV with price predictions
08:00 PM EDT Jun 07, 2023

IQV in upward trend: 10-day moving average crossed above 50-day moving average on May 24, 2023

The 10-day moving average for IQV crossed bullishly above the 50-day moving average on May 24, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 15, 2023. You may want to consider a long position or call options on IQV as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IQV just turned positive on May 11, 2023. Looking at past instances where IQV's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

IQV moved above its 50-day moving average on May 18, 2023 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IQV advanced for three days, in of 348 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 263 cases where IQV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IQV moved out of overbought territory on June 08, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IQV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IQV broke above its upper Bollinger Band on June 07, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IQV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.447) is normal, around the industry mean (29.021). P/E Ratio (37.037) is within average values for comparable stocks, (142.763). Projected Growth (PEG Ratio) (1.495) is also within normal values, averaging (5.650). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (2.695) is also within normal values, averaging (53.807).

A.I. Advisor
published Earnings

IQV is expected to report earnings to fall 2.86% to $2.38 per share on July 25

IQVIA Holdings IQV Stock Earnings Reports
Q2'23
Est.
$2.38
Q1'23
Beat
by $0.04
Q4'22
Beat
by $0.02
Q3'22
Beat
by $0.09
Q2'22
Beat
by $0.06
The last earnings report on April 27 showed earnings per share of $2.45, beating the estimate of $2.41. With 790.95K shares outstanding, the current market capitalization sits at 38.26B.
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Align Technology (NASDAQ:ALGN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.36B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 1%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 24%. RSHUF experienced the highest price growth at 158%, while PFGTF experienced the biggest fall at -72%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -32%. For the same stocks of the Industry, the average monthly volume growth was 5% and the average quarterly volume growth was -94%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 55
SMR Rating: 83
Profit Risk Rating: 85
Seasonality Score: 14 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of biopharmaceutical development services and commercial outsourcing services

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
2400 Ellis Road
Phone
+1 919 998-2000
Employees
86000
Web
https://www.iqvia.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MIMO0.230.10
+73.81%
Airspan Networks Holdings
SNFCA8.450.15
+1.81%
Security National Financial Corp
ROG157.122.23
+1.44%
Rogers Corp
FCNCA1283.466.84
+0.54%
First Citizens BancShares
DYN13.46-0.82
-5.74%
Dyne Therapeutics

IQV and

Correlation & Price change

A.I.dvisor indicates that over the last year, IQV has been closely correlated with ICLR. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then ICLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IQV
1D Price
Change %
IQV100%
-1.14%
ICLR - IQV
84%
Closely correlated
-0.53%
MTD - IQV
75%
Closely correlated
-2.42%
DHR - IQV
74%
Closely correlated
-0.89%
TMO - IQV
73%
Closely correlated
-1.06%
RVTY - IQV
73%
Closely correlated
-2.97%
More